Weber MA - Search Results

1

Rationale and design of the avoiding cardiovascular events through combination therapy in patients living with systolic hypertension (ACCOMPLISH) trial: the first randomized controlled trial to compare the clinical outcome effects of first-line combination therapies in hypertension.

Jamerson KA, Bakris GL, Wun CC, Dahlöf B, Lefkowitz M, Manfreda S, Pitt B, Velazquez EJ, Weber MA. Jamerson KA, et al. Among authors: weber ma. Am J Hypertens. 2004 Sep;17(9):793-801. doi: 10.1016/j.amjhyper.2004.05.004. Am J Hypertens. 2004. PMID: 15363822 Review.

2

Low-dose drug combination therapy: an alternative first-line approach to hypertension treatment.

Prisant LM, Weir MR, Papademetriou V, Weber MA, Adegbile IA, Alemayehu D, Lefkowitz MP, Carr AA. Prisant LM, et al. Among authors: weber ma. Am Heart J. 1995 Aug;130(2):359-66. doi: 10.1016/0002-8703(95)90454-9. Am Heart J. 1995. PMID: 7631621 Clinical Trial.

3

Coronary heart disease and hypertension.

Weber MA. Weber MA. Am J Hypertens. 1994 Oct;7(10 Pt 2):146S-153S. doi: 10.1093/ajh/7.10.146s. Am J Hypertens. 1994. PMID: 7826565 Review.

4

Application of ambulatory blood pressure monitoring in differentiating between antihypertensive agents.

Neutel JM, Smith DH, Ram CV, Kaplan NM, Papademetriou V, Fagan TC, Lefkowitz MP, Kazempour MK, Weber MA. Neutel JM, et al. Among authors: weber ma. Am J Med. 1993 Feb;94(2):181-7. doi: 10.1016/0002-9343(93)90181-n. Am J Med. 1993. PMID: 8430713 Clinical Trial.

5

Comparison of bisoprolol with atenolol for systemic hypertension in four population groups (young, old, black and nonblack) using ambulatory blood pressure monitoring. Bisoprolol Investigators Group.

Neutel JM, Smith DH, Ram CV, Lefkowitz MP, Kazempour MK, Weber MA. Neutel JM, et al. Among authors: weber ma. Am J Cardiol. 1993 Jul 1;72(1):41-6. doi: 10.1016/0002-9149(93)90216-y. Am J Cardiol. 1993. PMID: 8517426 Clinical Trial.

6

Hypertension in the elderly: 24 h ambulatory blood pressure results from a placebo-controlled trial.

Neutel JM, Smith DH, Lefkowitz MP, Cargo P, Alemayehu D, Weber MA. Neutel JM, et al. Among authors: weber ma. J Hum Hypertens. 1995 Sep;9(9):723-7. J Hum Hypertens. 1995. PMID: 8551485 Clinical Trial.

7

Antihypertensive therapy and quality of life. Influence of blood pressure reduction, adverse events, and prior antihypertensive therapy.

Weir MR, Prisant LM, Papademetriou V, Weber MA, Adegbile IA, Alemayehu D, Lefkowitz MP. Weir MR, et al. Among authors: weber ma. Am J Hypertens. 1996 Sep;9(9):854-9. doi: 10.1016/s0895-7061(96)00116-1. Am J Hypertens. 1996. PMID: 8879341 Clinical Trial.

8

Dose-related antihypertensive effects of irbesartan in patients with mild-to-moderate hypertension.

Pool JL, Guthrie RM, Littlejohn TW 3rd, Raskin P, Shephard AM, Weber MA, Weir MR, Wilson TW, Wright J, Kassler-Taub KB, Reeves RA. Pool JL, et al. Among authors: weber ma. Am J Hypertens. 1998 Apr;11(4 Pt 1):462-70. doi: 10.1016/s0895-7061(97)00501-3. Am J Hypertens. 1998. PMID: 9607385 Clinical Trial.

9

Implications of a health lifestyle and medication analysis for improving hypertension control.

Weir MR, Maibach EW, Bakris GL, Black HR, Chawla P, Messerli FH, Neutel JM, Weber MA. Weir MR, et al. Among authors: weber ma. Arch Intern Med. 2000 Feb 28;160(4):481-90. doi: 10.1001/archinte.160.4.481. Arch Intern Med. 2000. PMID: 10695688

10

Low-dose combination therapy: an important first-line treatment in the management of hypertension.

Neutel JM, Smith DH, Weber MA. Neutel JM, et al. Among authors: weber ma. Am J Hypertens. 2001 Mar;14(3):286-92. doi: 10.1016/s0895-7061(00)01310-8. Am J Hypertens. 2001. PMID: 11281242 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,169 results

Search Page

Filters